16
Jun
2027
National Exhibition and Convention Center
16 Jun 2027 - 18 Jun 2027
stand 62C02

Nanjing Hanxin Pharmaceutical Technology Co., Ltd

About Nanjing Hanxin Pharmaceutical Technology Co., Ltd

About Us Founded on July 6, 2021, through the restructuring of Amphastar Pharmaceuticals, Inc. (USA) China R&D Center, Nanjing Hanxin Pharmaceuticals Co., Ltd. has a registered capital of CNY 183 million. Leveraging advanced technology platforms and strong R&D capabilities, Hanxin has emerged as a global pharmaceutical Company- engaged in the research, manufacture, and sales of peptides, proteins, and polysaccharides (APIs and finished dosage forms).

Meet us at

  • CPHI & PMEC China 2027

    National Exhibition and Convention Center
    16 Jun 2027 - 18 Jun 2027
    stand 62C02
  • Country/Region:
    China
  • On CPHI since:
    2024
  • Employees:
    250 - 499
Company types
Biopharmaceutical company
CMO/CDMO
Machinery and Equipment Supplier/Manufacturer
Contact info